AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Vildapin-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Manith Healthcare Pvt Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Vildapin-M 50/1000 Tablet

Combiflex-DM 50/1000 tablets contain a dual-action formula designed to manage elevated blood glucose in individuals with type 2 diabetes. This helps mitigate the risk of serious diabetic complications like vision impairment and kidney disease, and may also lessen the probability of cardiovascular events such as stroke or heart attack. Combiflex-DM 50/1000 may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on your specific health status, blood sugar readings, and concurrent medications. Ingesting the tablets with food can minimize gastrointestinal distress. Consistent daily administration, at the same time each day, is crucial for maximum therapeutic benefit; discontinuation should only occur under your physician's guidance. Effective blood sugar control helps prevent future complications. Adherence to your prescribed diet and exercise regimen is paramount. Lifestyle choices significantly influence diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; therefore, familiarity with its symptoms and management is essential. This medication is not universally suitable. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Uses of Vildapin-M 50/1000 Tablet

Managing Type 2 diabetes

Major Benefits of Vildapin-M 50/1000 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the Vildapin-M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing. Administer this medication with a meal.

Common Side effects of Vildapin-M 50/1000 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildapin-M 50/1000 Tablet:

Consume this medication according to your physician's prescribed dosage and regimen. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildapin-M 50/1000 tablets with a meal.

How Vildapin-M 50/1000 Tablet works:

Vildapin-M 50/1000 tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildapin-M 50/1000 Tablet with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildapin-M 50/1000 tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before recommending this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildapin-M 50/1000 tablets while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildapin-M 50/1000 tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver disease should likely avoid Vildapin-M 50/1000 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildapin-M 50/1000 Tablet :

Should you forget a Vildapin-M 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildapin-M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildapin-M 50/1000 Tablet

Vildapin-M 50/1000 Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood glucose monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildapin-M 50/1000 Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first talking to your doctor.
Vildapin-M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildapin-M 50/1000 tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildapin-M 50/1000 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue use and seek immediate medical attention.
Prolonged Vildapin-M 50/1000 Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Vildapin-M 50/1000 Tablet is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildapin-M 50/1000 Tablet
168
MRP 195
13% off